Content about Autoimmunity

October 17, 2012

Study: Vitamin D supplementation helps people with lupus erythematosus

Vitamin D supplementation could be considered an immunomodulatory agent for systemic lupus erythematosus, an autoimmune disease characterized not only by skin, joint, neurological and renal symptoms, but also by inflammation of tissue linings in the body, according to a new clinical study published Tuesday in BioMedCentral's open access journal Arthritis Research and Therapy.

December 23, 2011

Baxter, Momenta partner on biosimilar development

Baxter and Momenta have agreed to partner to develop and market biosimilar drugs to treat cancer, autoimmune disorders and other chronic conditions.

December 20, 2011

Reports: Teva developing Type 1 diabetes drug

Israeli drug maker Teva Pharmaceutical Industries is developing a protein that could offer a new way to treat Type 1 diabetes, according to published reports.

November 7, 2011

Preliminary study: Vitamin D helped improve cell counts associated with lupus

The first study to report the effects vitamin D has on the immune system of people with lupus was unveiled Saturday at the American College of Rheumatology Annual Scientific Meeting in Chicago.

October 11, 2011

PhRMA: 900+ biotech drugs in development

Drug makers have 901 biotech drugs under development for more than 100 diseases ranging from cancers and infectious diseases to autoimmune disorders and cardiovascular diseases, the Pharmaceutical Research and Manufacturers of America said. 

April 22, 2011

Report: Many Type 1 diabetics have other immune diseases

Many children with Type 1 diabetes have other autoimmune disorders as well, according to published reports.

February 25, 2011

PhRMA: More than 400 rare disease treatments in development, pending approval

More than 400 drugs are in late-stage clinical development or awaiting Food and Drug Administration approval as treatments for rare diseases, according to a report by the drug industry lobby.

February 3, 2011

Lilly, JDRF enter research agreement

Drug maker Eli Lilly and the Juvenile Diabetes Research Foundation will fund research to find ways to regenerate insulin-producing cells in patients with Type 1 diabetes.

November 2, 2010

Tolerx's scientific advisory board to advance Type 1 diabetes research

A company that develops drugs for treating autoimmune diseases and cancer has created a scientific...

August 23, 2010

Roche to acquire BioImagene

Swiss drug maker Roche will acquire a U.S. diagnostics company that develops technology used to...

January 19, 2010

JDRF, Axxam, Fast Forward to develop diabetes, MS treatments

A group of companies and organizations plan to collaborate to develop new treatments for multiple...